Top Markets
Coin of the day
Neovasc Inc. Neovasc Inc.

Neovasc Inc.

NVCN
Rank in Stocks #17840
Neovasc Inc. is a medical technology firm specializing in the design,... Neovasc Inc. is a medical technology firm specializing in the design, production, and global distribution of cardiovascular devices, particularly across European markets and beyond. Its primary offerings include the Tiara system, developed for the transcatheter treatment of mitral valve disease, and the Neovasc Reducer, used to address chronic, debilitating chest pain known as refractory angina. Established in 2000, the company, which maintains its headquarters in Richmond, Canada, was formerly named Medical Ventures Corp. before adopting its current identity, Neovasc Inc., in July 2008.
Share Price
$29.82
Last synced: 2023-04-11
Market Cap
$223.68M
Change (1 day)
1.21%
Change (1 year)
0.00%
Country
CA
Trade Neovasc Inc. (NVCN)

Category

P/B ratio for Neovasc Inc. (NVCN)
P/B ratio as of 2026 TTM: 0
According to Neovasc Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Neovasc Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
3.7633 -
US
5.1766 -
US
2.0146 -
IE
2.8627 -
US
4.9264 -
US